🇺🇸 FDA
Patent

US 11370831

Compositions and methods for treating and preventing Staphylococcus aureus infections

granted A61KA61K2039/505A61K2300/00

Quick answer

US patent 11370831 (Compositions and methods for treating and preventing Staphylococcus aureus infections) held by XBIOTECH INC. expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XBIOTECH INC.
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/505, A61K2300/00, A61K38/12, A61K38/14